[1] |
YAO Y, YE Y, CHEN J, et al. Maternal-fetal immunity and recurrent spontaneous abortion[J]. Am J Reprod Immunol, 2024, 91(5):e13859. doi:10.1111/aji.13859
doi: 10.1111/aji.13859
|
[2] |
TANG C, HU W. The role of Th17 and Treg cells in normal pregnancy and unexplained recurrent spontaneous abortion (URSA): New insights into immune mechanisms[J]. Placenta, 2023, 142:18-26. doi:10.1016/j.placenta.2023.08.065
doi: 10.1016/j.placenta.2023.08.065
|
[3] |
LI QH, ZHAO QY, YANG W J, et al. Beyond Immune Balance: The Pivotal Role of Decidual Regulatory T Cells in Unexplained Recurrent Spontaneous Abortion[J]. J Inflamm Res, 2024, 17:2697-2710. doi:10.2147/jir.s459263
doi: 10.2147/jir.s459263
|
[4] |
李静,裴建赢,刘倩,等. 肿瘤坏死因子-瘤基因-环境交互作用与不明原因复发性流产易感性的关系[J]. 实用医学杂志, 2022, 38(22):2822-2827.
|
[5] |
XU X, DENNETT P, ZHANG J, et al. CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis[J]. J Exp Med, 2023, 220(7):e20221391. doi:10.1084/jem.20221391
doi: 10.1084/jem.20221391
|
[6] |
TANG D, KANG R, ZEH H J, et al. The multifunctional protein HMGB1: 50 years of discovery[J]. Nat Rev Immunol, 2023, 23(12):824-841. doi:10.1038/s41577-023-00894-6
doi: 10.1038/s41577-023-00894-6
|
[7] |
中华医学会妇产科学分会产科学组,复发性流产诊治专家共识编写组. 复发性流产诊治专家共识(2022)[J]. 中华妇产科杂志, 2022, 57(9):653-667.
|
[8] |
LI M M, LIN J, WU H F, et al. Analysis of the risk factors in patients with unexplained recurrent spontaneous abortion[J]. Am J Reprod Immunol, 2023, 90(4):e13774. doi:10.1111/aji.13774
doi: 10.1111/aji.13774
|
[9] |
YANG P, LU F. Study on the immunomodulatory mechanism of vitamin D in patients with unexplained recurrent spontaneous abortion[J]. Heliyon, 2024, 10(6):e27280. doi:10.1016/j.heliyon.2024.e27280
doi: 10.1016/j.heliyon.2024.e27280
|
[10] |
DU M, LI Y, GU H, et al. Assessment of the risk of unexplained recurrent spontaneous abortion based on the proportion and correlation of NK cells and T cells in peripheral blood[J]. Technol Health Care, 2023, 31(S1):97-109. doi:10.3233/thc-236010
doi: 10.3233/thc-236010
|
[11] |
付枭,郭海春,李华,等. 不明原因复发性流产蜕膜组织中调节性T细胞亚群水平及预测价值[J]. 中国计划生育学杂志,2023,31(10):2401-2404.
|
[12] |
FRANKEN A, BILA M, MECHELS A, et al. CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy[J]. Immunity, 2024, 57(3):541-558.e7. doi:10.1016/j.immuni.2024.02.007
doi: 10.1016/j.immuni.2024.02.007
|
[13] |
毕晓英,王丹丹,许珂. CTLA4基因多态性与不明原因习惯性流产发生风险关系[J]. 中国计划生育学杂志, 2020, 28(1):80-84,92.
|
[14] |
HAN X, REN Y, ZHANG X, et al. HMGB1 induces unexplained recurrent spontaneous abortion by mediating decidual macrophage autophagy[J]. Int Immunopharmacol, 2025,147:113999. doi:10.1016/j.intimp.2024.113999
doi: 10.1016/j.intimp.2024.113999
|
[15] |
HOSSEN M M, MA Y, YIN Z, et al. Current understanding of CTLA-4: From mechanism to autoimmune diseases[J]. Front Immunol, 2023, 14:1198365. doi:10.3389/fimmu.2023.1198365
doi: 10.3389/fimmu.2023.1198365
|
[16] |
MIRAKI FERIZ A, KHOSROJERDI A, ERFANIAN N, et al. Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT[J]. Immunobiology, 2024, 229(4):152822. doi:10.1016/j.imbio.2024.152822
doi: 10.1016/j.imbio.2024.152822
|
[17] |
VADDI P K, OSBORNE D G, NICKLAWSKY A, et al. CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients[J]. Front Immunol, 2023, 14:1173035. doi:10.3389/fimmu.2023.1173035
doi: 10.3389/fimmu.2023.1173035
|
[18] |
REN Y, ZHU D, HAN X, et al. HMGB1: A double-edged sword and therapeutic target in the female reproductive system[J]. Front Immunol, 2023, 14:1238785. doi:10.3389/fimmu.2023.1238785
doi: 10.3389/fimmu.2023.1238785
|
[19] |
HE L, SONG Q, HU J, et al. Expression of HMGB1-TLR4 in Placentas from Preeclamptic Pregnancies and Its Effect on Proliferation and Invasion of HTR-8/SVneo Cells[J]. Gynecol Obstet Invest, 2023, 88(3):159-167. doi:10.1159/000530006
doi: 10.1159/000530006
|
[20] |
SUN J, JIANG Y, LI L, et al. HMGB1/RAGE Signaling Regulates Th17/IL-17 and Its Role in Bronchial Epithelial-Mesenchymal Transformation[J]. Curr Mol Med, 2024, 24(11):1401-1412. doi:10.2174/0115665240249953231024060610
doi: 10.2174/0115665240249953231024060610
|
[21] |
ZHU X, DOU Y, LIN Y, et al. HMGB1 regulates Th17 cell differentiation and function in patients with psoriasis[J]. Immun Inflamm Dis, 2024, 12(2):e1205. doi:10.1002/iid3.1205
doi: 10.1002/iid3.1205
|
[22] |
ZHANG G, YANG P, LIU X, et al. HMGB1 is increased in patients with immune thrombocytopenia and negatively associates with Tregs[J]. Thromb Res, 2022, 213:128-136. doi:10.1016/j.thromres.2022.02.021
doi: 10.1016/j.thromres.2022.02.021
|
[23] |
BHARDWAJ C, SRIVASTAVA P. Identification of hub genes in placental dysfunction and recurrent pregnancy loss through transcriptome data mining: A meta-analysis[J]. Taiwan J Obstet Gynecol, 2024, 63(3):297-306. doi:10.1016/j.tjog.2024.01.035
doi: 10.1016/j.tjog.2024.01.035
|
[24] |
储莉鸣,马梓汶,陈守真. 外周血IL-17、HMGB1水平诊断不明原因复发性流产价值及其与Th17/Treg细胞关系[J]. 中国计划生育学杂志, 2022, 30(3):633-637.
|
[25] |
张维平,王文文,张调平,等. 主动免疫治疗对原因不明性复发性流产患者Treg/Th17免疫平衡的影响[J]. 中国妇产科临床杂志, 2021, 22(3):249-251.
|
[26] |
WANG W, ZHAO Y, ZHOU X, et al. Dynamic changes in regulatory T cells during normal pregnancy, recurrent pregnancy loss, and gestational diabetes[J]. J Reprod Immunol, 2022, 150:103492. doi:10.1016/j.jri.2022.103492
doi: 10.1016/j.jri.2022.103492
|